全部资讯｜CELL INTELLIGENCE

ALL SOURCES

全部资讯 19

把在研试验和前沿论文合在一起看，按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和（导航里的「临床试验」板块只收在招的那部分，不另计入）。

Multi-Omics-Enabled Precision Strategies for Overcoming CAR-T Therapy Limitations in Gastrointestinal Malignancies.

PubMed 2026/09/01 发表BiofactorsQ1 · IF 5.2（JCR 2025）

Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities.

PubMed 2026/07/03 发表ImmunobiologyQ3 · IF 3.1（JCR 2025）

Common gamma chain cytokines-driven optimization of chimeric antigen receptor T cells: Mechanistic insights and future directions.

PubMed 2026/02/24 发表World J Clin OncolQ2 · IF 3.6（JCR 2025）

Pleiotropic and multicellular roles of lymphotoxin beta receptor in solid tumor immunity and therapeutic targeting.

PubMed 2026/02/04 发表Front ImmunolQ1 · IF 7（JCR 2025）

Human germline-like monoclonal antibody against 5T4 enables potent ADC and CAR-T therapies for solid tumors.

PubMed 2026/01/27 发表Acta Pharmacol SinQ1 · IF 10.4（JCR 2025）

Multifaceted role of interleukin-32 in inflammatory diseases and cancer.

PubMed 2026/01/06 发表Biomed Pharmacother

Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications.

PubMed 2025/07/11 发表Antibodies (Basel)Q3 · IF 3.3（JCR 2025）

Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights.

PubMed 2025/05/31 发表Mol TherQ1 · IF 11.4（JCR 2025）

Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression.

PubMed 2025/01/02 发表Sci RepQ1 · IF 4.9（JCR 2025）

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors.

PubMed 2024/11/22 发表Signal Transduct Target TherQ1 · IF 81.2（JCR 2025）